Clinical Trials Browser

Phase 1 × Breast Neoplasms × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT00436254 2025-04-06

Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer

Phase 1 Completed

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms

NCT02019524 2020-03-18

J65

Phase 1 Completed

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Male

NCT00027807 2016-02-17

Biological Therapy in Treating Women With Stage IV Breast Cancer

Phase 1 Completed

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00028496 2013-01-25

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Phase 1 Completed

BreastGastrointestinalGenitourinaryHead & Neck

Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Carcinoma, Medullary, Breast Neoplasms, Male